Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians

Marta Barretta,1 Giovanni Grandi2 1Department of Obstetrics and Gynecology, Ramazzini Hospital, Carpi (MO), 41012, Italy; 2Department of Medical and Surgical Sciences for Mother, Child and, Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Di Modena, Modena, ItalyCorrespondence: Marta Barretta, Department of Obstetrics and Gynecology, Ramazzini Hospital, Azienda USL di Modena, Via Guido Molinari 2, Carpi (MO), 41012, Italy, Email [email protected]: Abnormal uterine bleeding (AUB) is a common side effect of hormonal contraceptive (HC) use and represents a significant cause of treatment discontinuation. Two main types of bleeding are recognized: withdrawal bleeding, which occurs during the hormone-free interval following a sudden drop in hormone levels, and breakthrough bleeding (BTB), defined as unscheduled bleeding during active hormone administration. Combined oral contraceptives (COCs) may induce BTB due to hormonal fluctuations or insufficient endometrial stabilization, while progestin-only contraception (POC) is commonly associated with abnormal bleeding due to endometrial changes induced by continuous progestin exposure. A structured and clinically oriented framework for the management of AUB in the context of HC is presented, highlighting the importance of appropriate counseling. Some strategies to improve adherence have been proposed, recognizing non-compliance as a major contributor to unscheduled bleeding. Contraceptive choice is addressed as an individualized process, involving adjustments to hormone type and dosage based on woman-specific needs. The aim is to provide clinicians with a clear and structured tool to address a highly prevalent yet often overlooked issue, still marked by significant uncertainty and inconsistency in the current literature.Keywords: abnormal uterine bleeding, hormonal contraception, progestin-only contraception, combined oral contraceptives, breakthrough bleeding, withdrawal bleeding

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-10-01
Primary Topic
Reproductive Health and Contraception
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians

SHILAP Revista de lepidopterología
Reproductive Health and Contraception
article

Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians

article en

Abstract

Marta Barretta,1 Giovanni Grandi2 1Department of Obstetrics and Gynecology, Ramazzini Hospital, Carpi (MO), 41012, Italy; 2Department of Medical and Surgical Sciences for Mother, Child and, Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Di Modena, Modena, ItalyCorrespondence: Marta Barretta, Department of Obstetrics and Gynecology, Ramazzini Hospital, Azienda USL di Modena, Via Guido Molinari 2, Carpi (MO), 41012, Italy, Email [email protected]: Abnormal uterine bleeding (AUB) is a common side effect of hormonal contraceptive (HC) use and represents a significant cause of treatment discontinuation. Two main types of bleeding are recognized: withdrawal bleeding, which occurs during the hormone-free interval following a sudden drop in hormone levels, and breakthrough bleeding (BTB), defined as unscheduled bleeding during active hormone administration. Combined oral contraceptives (COCs) may induce BTB due to hormonal fluctuations or insufficient endometrial stabilization, while progestin-only contraception (POC) is commonly associated with abnormal bleeding due to endometrial changes induced by continuous progestin exposure. A structured and clinically oriented framework for the management of AUB in the context of HC is presented, highlighting the importance of appropriate counseling. Some strategies to improve adherence have been proposed, recognizing non-compliance as a major contributor to unscheduled bleeding. Contraceptive choice is addressed as an individualized process, involving adjustments to hormone type and dosage based on woman-specific needs. The aim is to provide clinicians with a clear and structured tool to address a highly prevalent yet often overlooked issue, still marked by significant uncertainty and inconsistency in the current literature.Keywords: abnormal uterine bleeding, hormonal contraception, progestin-only contraception, combined oral contraceptives, breakthrough bleeding, withdrawal bleeding

SHILAP Revista de lepidopterología
Mother Hospital (IN)
Good health and well-being
Openalex Percentile: Top 35%
Reproductive Health and Contraception
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.